Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2005-01-30 Capital/Financing Update
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
VRI to List on AIM 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an announcement from VRI BioMedical Ltd dated 31 January 2005 regarding the company's intention to list on the AIM exchange in London, which will result in a dual listing. It discusses the rationale for the listing, including establishing a presence in the Northern Hemisphere and raising capital for R&D and commercial activities. The document does not contain financial statements, detailed financial performance data, or management discussion of results. It is primarily an update on capital raising and listing plans. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 3401 characters, which is consistent with an announcement rather than a full report.
2005-01-30 English
Commitments Test Entity - Second Quarter Report 6 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C - Quarterly cash report' and is dated 31st January 2005, covering the quarter ended 31 December 2004. It contains detailed quarterly cash flow statements and operational financial data for the quarter and year-to-date periods. The presence of actual financial data and the quarterly period covered indicate this is a quarterly financial report. Appendix 4C is a known Australian Securities Exchange (ASX) form for quarterly cash flow reporting by entities. The document is not merely an announcement or a certification but contains substantive financial data. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2005
2005-01-30 English
Licensing Agreement with Largest Distributor in Asia 1
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated January 25, 2005, from VRI BioMedical Ltd to the Australian Stock Exchange. It details a licensing agreement with a distributor in Asia, describing the business arrangement and strategic importance. There are no financial statements, regulatory certifications, or detailed financial data. The document is an update on a capital-related business development (licensing agreement) rather than a full financial report or earnings release. It is not a report publication announcement since it contains substantive content about the agreement itself. Therefore, the best fitting category is Capital/Financing Update (CAP).
2005-01-24 English
Form 484 - Selective reduction of capital 13 pages ?Kb
Regulatory Filings Classification · 100% confidence The document is a form used to notify the Australian Securities and Investments Commission (ASIC) of changes to company details such as address, name of officeholders or members, changes to share structure, and appointment or cessation of company officeholders. It includes sections for lodging changes to company officeholders, share cancellations, share issues, and changes to the register of members. The document is a regulatory filing form for administrative updates rather than a financial report or announcement. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a formal notification to a regulatory body about company details changes. Therefore, it fits best under Regulatory Filings (RNS).
2004-11-29 English
Results of AGM 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULT OF ANNUAL GENERAL MEETING' and details the voting results of resolutions passed at the AGM, including election of directors and special resolutions. It provides specific vote counts for each resolution. The document is short (3365 characters) and focuses solely on the outcome of the shareholder votes at the AGM, not the full AGM materials or presentations. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2004-11-25 English
Final Director's Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Final Director's Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the securities holdings and interests of a director, Sally Anne Capp, including dates of last notice and cessation as director. The content focuses on personal share transactions and holdings by a company director. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and specific to director interests, not a broader financial or management report.
2004-11-25 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.